BioFluidica
PrivateLast Round
Series B
Extension
Feb 8, 2022
Total Funding Raised
$15.4M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
BioFluidica operates in Healthcare & Life Sciences and is based in Lawrence, Kansas. Its latest recorded funding round was a Series B Extension round in February 2022.
BioFluidica is a biotechnology company that provides a liquid biopsy platform for the isolation and analysis of rare cells, extracellular vesicles, and cfDNA.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Precision Medicine, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Usage-Based SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioFluidica Comparables
Compare BioFluidica with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vortex Biosciences | 83% | |
| Creatv MicroTech, Inc. | 81% | |
| Cytotrait | 80% |
For institutional investors. Book with your work email.
BioFluidica Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Feb 8, 2022 | ||||
| Grant | Aug 12, 2021 | ||||
| Grant | Jan 10, 2019 | ||||
| Grant | Jan 7, 2019 | ||||
| Series B | Jul 21, 2017 | ||||
Series A | Apr 4, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BioFluidica Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 37% MoM, reaching 1.8K.
- May 12, 2026
Monthly visitors increased 334% MoM, reaching 2K.
For institutional investors. Book with your work email.
BioFluidica Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BioFluidica's valuation, stock price, and market status.
Is BioFluidica a public or private company?
BioFluidica is a private company.
What is the current stock price of BioFluidica?
BioFluidica is a private company, so its shares have no public market price. Caplight tracks BioFluidica's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BioFluidica worth (valuation)?
Valuation information for BioFluidica is not publicly available.
Can I buy BioFluidica stock?
BioFluidica shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BioFluidica's last funding round?
BioFluidica's most recent funding round was Series B Extension on February 8, 2022.
Who are the main investors in BioFluidica?
Key investors in BioFluidica include National Cancer Institute, National Institutes of Health (NIH).
Will BioFluidica IPO soon?
No public IPO plans have been announced for BioFluidica.
How can I track BioFluidica secondary market activity?
Caplight tracks bids, offers, and trades in BioFluidica's shares on secondary markets.